Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials. - Mateos MV; Trudel S; Quach H; Robak P; Beksac M; Pour L; Hus M; Kim K; Zherebtsova V; Delimpasi S; Jelínek T; Ward C; et al. (Blood advances, 2025)